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Background. Impaired endothelial-dependent vascular responses after coronary artery occlusion (CAO) and reperfusion (CAR) have been investigated extensively. However, it is not known whether impaired endogenous endothelium-derived relaxing factor production affects postischemic myocardial dysfunction, ie, myocardial stunning. 30-minute CAR, not only in the subendocardium (-76±91% versus -49±9%o) but also in the subepicardium (-52±8% versus -29±7%o). During CAO, blood flow was decreased identically in both conditions, and during CAR, the differences in blood flow were minor (7%).
Conclusions. Inhibition of NO synthesis enhanced myocardial stunning transmurally in conscious dogs, potentially independent of its effects on blood flow. (Circulation. 1993; 88:2862 -2871 KEY WORDS * myocardium * relaxing factors * coronary artery * occlusion * flow NG-nitro-L-arginine T he endothelium plays a significant role in modulating coronary vasomotor tone and myocardial contraction via the synthesis and metabolism of vasodilating and vasoconstricting agents.1-3 Several studies have demonstrated impaired endothelium-dependent vascular responses after coronary artery occlusion (CAO) and its relief by reperfusion (CAR) both in vitro4-6 and in vivo. 7, 8 Most prior studies on the role of the endothelium in myocardial ischemia have focused on either altered endothelial control of vascular function4-8 or the development of myocardial necrosis.9-'1 However, the extent to which endothelial function modulates the recovery of regional myocardial function following a brief period of CAO, insufficient to induce myocardial necrosis, ie, myocardial stunning,12"13 is not known.
Accordingly, the primary goal of the current investigation was to determine whether inhibition of endogenous endothelium-derived relaxing factor (EDRF), eg, nitric oxide (NO),14 enhances postischemic myocardial dysfunction. A second goal was to determine if the alterations in myocardial stunning, by the inhibition of endogenous EDRF, was nonuniform transmurally since it has been suggested that endothelium-dependent vasodilation is most prominent in the subendocardium15 and is selectively attenuated in the subendocardium after ischemia and reperfusion. 16 Since systemic administration of NO synthesis inhibitors increases arterial and left ventricular pressures, ie, afterload, and potentially preload, which would, by itself, affect myocardial stunning,17,18 it was thought to be critical to avoid these complicating issues by administering the NO synthesis inhibitor locally. To accomplish this, an infusion of N0-nitro-L-arginine (L-NA) was administered intracoronary to inhibit the NO synthesis pathway selectively in the territory of the left circumflex coronary artery, which was destined to become ischemic, relatively sparing the nonischemic zone and systemic circulation. L-NA was selected since it is more potent than NGmonomethyl-L-arginine (L-NMMA) as Total left circumflex coronary blood flow was measured using a Doppler ultrasonic flowmeter in seven dogs. In one Experimental Protocol At 1 to 2 weeks after surgery, when the animals were healthy and had recovered from surgery and trained to lie quietly on their right sides, the effects of an initial 10-minute CAO were examined and discarded. Preliminary data from our laboratory suggested that myocardial stunning following an initial CAO was enhanced significantly compared with that observed in the same conscious dogs following subsequent second and third periods of CAO, but there was no significant difference between the myocardial stunning observed following the second and the third CAO.23 Therefore, in this study we discarded the results from the first CAO and randomized the second and the third CAO with and without EDRF inhibition in the same eight dogs, ie, four dogs underwent the experiment with L-NA before the saline control, whereas the other four dogs experienced the reverse sequence. Aortic pressure; LV pressure; rate of change of LV pressure (dP/dt); LV full, subendocardial, and subepicardial wall thicknesses; heart rate; and lead II ECG were monitored continuously throughout the study. All animals received an injection of morphine sulfate (0.3 to 0.5 mg/kg IM) before CAO. After control measurements were recorded, including the first injection of microspheres in five dogs, CAO was accomplished by inflating the hydraulic occluder. In three dogs, microspheres were not given because of technical difficulties. At 5 minutes after CAO, the second injection of microspheres was performed. Ventricular premature contractions were prevented and treated with bolus left atrial injections of 2% lidocaine, and the identical total amounts of lidocaine were used in the experiments with and without L-NA. Reperfusion was carried out after 10 minutes of CAO. The coronary artery occluder was released slowly over 30 seconds. The third injection of microspheres was given at 30 minutes after CAR. In five dogs, L-NA was infused at a rate of 30 ttg * kg1 . min1 IC for 12 minutes in 0.5 mUmin of saline before CAO, and at a maintenance dose of L-NA (6 ,ug * kg-1 . min-1 delivered in 0.1 mLmin of saline) starting simultaneously with CAR and continuing up to 1 hour after CAR. In the other three dogs, twice the dose of L-NA was administered intracoronary. Ten minutes were allowed after the completion of initial loading of L-NA before any intervention. In the control CAO experiment, the same volumes of saline were administered during the same periods. Hemodynamics were monitored continuously for 6 hours and then intermittently until full recovery of regional myocardial function was confirmed at 24 hours after CAR. At least 48 hours elapsed between each 10-minute CAO and 24-hour CAR.
L-NA was dissolved in saline following 20 to 30 minutes of sonication as described by Moore et coronary blood flow to acetylcholine was diminished by 37±6% (P<.01), and the total coronary blood flow response (the area of increased mean coronary blood flow determined by planimetry) to acetylcholine was diminished by 58±4% (P<.01). In contrast, the peak coronary blood flow response to nitroglycerine 0.2 ptg/kg IC (dissolved in 0.3±0.02 mL of saline) was not affected (2.9±4.5%, NS). The amount of inhibition of the coronary blood flow response to acetylcholine we observed was similar to the results by Parent et a120 with intracoronary L-NAME in conscious dogs.
After the final experiments were completed, the dogs were anesthetized with an overdose of pentobarbital (50 mg/kg IV) to retrieve the heart for microsphere blood flow analysis. Four to six transmural specimens ( 
Results

Systemic Hemodynamics
There were no significant differences in baseline systemic hemodynamics with and without intracoronary L-NA, verifying that intracoronary administration of L-NA in the present study did not affect systemic hemodynamics (Table 1) . During CAO (just before CAR), heart rate, LV end-diastolic pressure, LV systolic pressure, and mean aortic pressure increased significantly and similarly in both conditions. Furthermore, there were no significant differences in systemic hemodynamics during CAO between the two conditions. After CAR, all measurements of systemic hemodynamics returned to baseline levels by 30 minutes, and there were no significant differences between the two conditions. No significant differences were observed in the three dogs with twice the dose of L-NA compared with the other five dogs studied.
Regional Myocardial Function
During CAO, systolic wall thickening was replaced by wall thinning, which was more prominent subendocardially than subepicardially (Table 2 and Figs 2 through 4). The extent of wall thinning during CAO tended to be greater in the presence of L-NA but did not reach statistical significance. In the nonischemic zone, there were also no significant differences in transmural systolic wall thickening between the two conditions. There were no significant differences in nonischemic zone wall thickening between the two conditions throughout the entire CAR period. In contrast, the recovery of systolic wall thickening in the ischemic zone was significantly delayed in the presence of L-NA (Figs 2 through 4). The recovery of subendocardial systolic wall thickening was delayed more than in the subepicardium under both conditions. The extent of postischemic dysfunction (myocardial stunning) was more prominent (P<.05) in the presence of L-NA than in the absence of L-NA, not only in the subendocardium but also in the subepicardium and transmurally (Figs 2 through 4) .
The average data at 30 minutes after CAR for all eight dogs studied are summarized in Table 2 Regional Myocardial Blood Flow Myocardial blood flow in the distribution of the left circumflex territory, which received the L-NA, tended to decrease with L-NA before CAO, ie, transmural myocardial blood flow was decreased slightly but significantly (-8.3±1.7%, P<.05) ( Table 37 and Figs 5 and   6 ). However, there were no significant differences in the left anterior descending territory and the right ventricular territory (Fig 5) . The endo/epi ratios were not significantly different.
During CAO, endocardial blood flow was significantly lower than epicardial blood flow under both conditions, and there were no differences between L-NA(-) CAO and L-NA(+) CAO for either endo/epi ratios (0.24±0.05 versus 0.24±0.06) or transmural blood flow (0.18±0.05 versus 0.18±0.06 mL* min-1 . g-'). After 30-minute CAR, blood flow recovered faster in epicardial layers compared with endocardial layers, but the recovery of blood flow was similar in both conditions. At 30 minutes after CAR, the endo/epi ratios were similar under both conditions. Transmural blood flow was depressed only modestly more in the presence of L-NA, by 7.0±1.4%, P<.05. There were also no major differences observed in the one dog that received twice the dose of L-NA (blood flow during CAR was reduced by 8.0% with L-NA) compared with the responses in the other four dogs.
There were also no differences in the presence and absence of L-NA in the pattern of total left circumflex coronary blood flow using the Doppler flowmeter (Fig  6) . L-NA did not affect baseline coronary blood flow measured by Doppler flow probe not only in the group of five dogs but also in two dogs that received twice the dose of L-NA. After CAR, the amount of reactive hyperemia was similar in the presence and absence of L-NA (Fig 6) . The peak hyperemic responses were 389±35% in L-NA(-) CAO and 379±48% in L-NA(+) CAO. The total debt-repayment ratios were 0.82±0.10 in L-NA(-) CAO and 0.78±0.11 in L-NA(+) CAO. There were no significant differences observed in the two dogs with twice the dose of L-NA from the other five dogs studied.
Discussion
Impaired endothelium-dependent vascular responses after CAO and CAR have been demonstrated.4-8 NO synthesis inhibitors have been shown to alter vascular responses to CAO and CAR,30 and NO mechanisms have been shown to affect infarct size.9-1 However, the results of the present investigation are the first to demonstrate a role of endogenous NO synthesis inhibition in myocardial stunning, particularly in the conscious animal. The experimental design used several advantageous features. First, the study of the conscious animal eliminates complicating influences of anesthesia and recent surgery and allowed the study of the same animals with and without NO synthesis inhibition on separate days. Second, regional myocardial function was assessed continuously during CAO and CAR in both the subendocardium and the subepicardium as well as transmurally and were compared with measurements of regional myocardial blood flow. Third, the intracoronary catheter permitted local administration of L-NA selectively to the potential ischemic zone, eliminating complicating effects of L-NA-induced systemic hypertension and increases in afterload, which would affect the extent of myocardial stunning. '8 In support of the contention that the L-NA acted only locally, intracoronary administration of L-NA reduced coronary blood flow selectively in the perfusion bed of the left circumflex coronary artery but not in the left anterior descending coronary artery territory or right ventricle (Fig 5) , and there were no effects on systemic hemodynamics. Therefore, discrete local inhibition of NO synthesis was achieved. Finally, the present experimental design discarded the effects of the initial 10-minute CAO since myocardial stunning is always most severe during the first CAO, but there is little difference between results of a second and third CAO.23 By discarding the results from the first CAO and randomizing the second and third CAO with and without L-NA, we were able to more accurately assess the effects of inhibition of NO synthesis.
The major finding of the current investigation was that inhibition of endogenous NO synthesis enhances myocardial stunning transmurally and in both subendocardial and subepicardial layers (Figs 3 and 4) . Even if EDRF control is more potent in the subendocardium,'5 this was not reflected in our results, either during CAO or CAR, or on either transmural myocardial function or blood flow.
Several possible mechanisms were considered to explain the adverse effects of NO All values given in mL-min-1 . g-'.
recovery of regional myocardial function. First, myocardial loading conditions, particularly afterload, could be altered by NO synthesis inhibition, which, during CAR, would enhance myocardial stunning.18 However, that was not observed using intracoronary administration of L-NA. LV systolic pressures and mean arterial pressures were almost identical during CAR with and without L-NA. Second, inhibition of NO synthesis might induce more intense ischemia during CAO, which could affect the recovery of regional function. 31 The measurement of myocardial blood flow with microspheres ruled out the possibility that depression in blood flow during CAO differed in the presence and LV-LCX absence of L-NA. However, we cannot exclude the possibility that the mismatch between oxygen demand and supply was not more severe in the presence of L-NA, particularly during CAO, where increased LV systolic pressure and mean arterial pressure tended to be greater in the presence of L-NA treatment, as was the extent of regional myocardial wall thinning. Thus, it is possible that myocardial oxygen demands were augmented in the face of similar levels of perfusion. It has been suggested that more intense ischemia enhances myocardial stunning31'32; however, this concept is based on levels of myocardial dysfunction from partial loss (hypokinesis) to complete loss of function (dyskinesis). When wall motion is lost more than 100%, ie, paradoxical thinning evolves, there is no longer a relation among blood flow reduction, decreased wall motion during CAO, and extent of myocardial stunning.31 Therefore, the enhanced myocardial stunning in the presence of NO synthesis inhibition cannot be related to the more intense myocardial wall thinning during CAO.
This leaves us with the intriguing possibility that the mechanism for the augmented myocardial stunning in the presence of L-NA involves EDRF but is independent of its effects on myocardial blood flow. For example, it is conceivable that augmented myocardial stunning following NO synthesis inhibition is due to other functions of NO, such as its action on oxygen radicals,33 on platelet aggregation,34 or on neutrophil aggregation.35 NO has also been shown to be released on reoxygenation following acute hypoxia.36 Perhaps during CAR, NO is released, which protects the myocardium independent of blood flow, eg, at the level of excitation-contraction coupling, which is known to be involved in the mechanism of myocardial stunning.37 '38 It is also conceivable that NO induces a protective effect on the myocardial cell in response to injury or transient ischemia. The inhibition of this protective influence would then result in augmented myocardial stunning. Finally, a direct effect of EDRF on regional myocardial function, independent of blood flow during CAR, must also be considered. Recently, the endothelium has been reported to affect myocardial function. 39 experiments blunting this mechanism with L-NA resulted in enhanced myocardial stunning.
In conclusion, intracoronary administration of L-NA provided local suppression of NO synthesis without significant changes in systemic hemodynamics. Inhibition of NO synthesis exerted only modest effects on the responses to CAO but enhanced myocardial stunning transmurally. Interestingly, the mechanism does not appear to relate to altered control of myocardial blood flow but rather to an effect on the myocardium.
